Rectal cancer

Open Access
Safety and Efficacy of SOX Therapy After Preoperative Chemoradiotherapy for Advanced Lower Rectal Cancer: A Phase I Study
MANABU YAMAMOTO, KEI URAKAMI, KOTARO OSAKI, CHIHARU YASUI, TAKUKI YAGYU, YUSUKE KONO, KYOICHI KIHARA, TOMOYUKI MATSUNAGA, NARUO TOKUYASU, SHUICHI TAKANO, TERUHISA SAKAMOTO and YOSHIYUKI FUJIWARA

In Vivo May 2026, 40 (3) 1577-1584; DOI: https://doi.org/10.21873/invivo.14307
Open Access
Prognosis and Risk Factors in Patients With Non-radical Circumferential Resection Margin After Rectal Cancer Surgery
BEATRICE EHRNROOTH, ERIK AGGER, PAMELA BUCHWALD and CECILIA DAHLBÄCK

In Vivo January 2026, 40 (1) 296-302; DOI: https://doi.org/10.21873/invivo.14192
Open Access
Impact of Adjuvant Chemotherapy Following Neoadjuvant Concurrent Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer
YU-SHIH LIU, JEN-KOU LIN, TZU-CHEN LIN, WEI-SHONE CHEN, SHUNG-HAUR YANG, HUANN-SHENN WANG, SHIH-CHING CHANG, YUAN-TZU LAN, CHUN-CHI LIN, HUNG-HSIN LIN and JENG-KAI JIANG

In Vivo July 2025, 39 (4) 2311-2319; DOI: https://doi.org/10.21873/invivo.14027
Open Access
Comparative Outcomes of Robot-assisted Versus Laparoscopic Low Anterior Resection in Mid-to-low Rectal Cancer: A Propensity Score–matched Study on Complications and Permanent Stoma Rates
HSIN HSU, JENG-FU YOU, CHUN-KAI LIAO, TZONG-YUN TSAI and SHU-HUAN HUANG

In Vivo July 2025, 39 (4) 2387-2396; DOI: https://doi.org/10.21873/invivo.14037
Open Access
Alteration of Apparent Diffusion Coefficient Measurements Predict Survival Outcomes During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
YUMA WADA, MASAAKI NISHI, TAKUYA TOKUNAGA, HIDEYA KASHIHARA, CHIE TAKASU, TOSHIAKI YOSHIMOTO and MITSUO SHIMADA

In Vivo March 2025, 39 (2) 927-935; DOI: https://doi.org/10.21873/invivo.13897
Open Access
Long-term Quality of Life After Surgery for Mid- and High Rectal Cancer: Hartmann’s Procedure Versus Anterior Resection and Abdominoperineal Resection
MARCUS LINDSKÖLD, ELIN MARIUSDOTTIR, JENS WIKSTRÖM, MARIE-LOUISE LYDRUP, FREDRIK JÖRGEN and PAMELA BUCHWALD

In Vivo July 2024, 38 (4) 1783-1789; DOI: https://doi.org/10.21873/invivo.13629
Open Access
Impact of Neoadjuvant Radiochemotherapy on Pathological Complete Response for Locally Advanced Rectal Cancer: A Mono Institutional Experience
MARCO LUCARELLI, VIRGINIA GENTILE, ROSARIO BONELLI, GIULIA DE PASQUALE, ANDREA DELLI PIZZI, MARTA DI NICOLA, ANNAMARIA PORRECA and DOMENICO GENOVESI

In Vivo May 2024, 38 (3) 1367-1374; DOI: https://doi.org/10.21873/invivo.13577
Open Access
Clinicopathological Outcomes in Patients With Locally Advanced Rectal Cancer Undergoing Preoperative Short-Versus Long-course Chemoradiotherapy With Delayed Surgery
JAE SIK KIM, MI JOO CHUNG, DOO YEUL LEE, SUK HWAN LEE, SEUNG-KYU JEONG, BYUNG EUN YOO, CHOON SIK CHUNG and WEON KUU CHUNG

In Vivo November 2023, 37 (6) 2768-2775; DOI: https://doi.org/10.21873/invivo.13388
Open Access
Rapid Reduction of CEA and Stable Metastasis in an NRAS-mutant Rectal-Cancer Patient Treated With FOLFIRI and Bevacizumab Combined With Oral Recombinant Methioninase and a Low-Methionine Diet Upon Metastatic Recurrence After FOLFIRI and Bevacizumab Treatment Alone
YUTARO KUBOTA, QINGHONG HAN, SEI MORINAGA, TAKUYA TSUNODA and ROBERT M. HOFFMAN

In Vivo September 2023, 37 (5) 2134-2138; DOI: https://doi.org/10.21873/invivo.13310
Open Access
Impact of Pattern Recognition Receptors on the Prognosis of Chemotherapy-treated Rectal Cancer Patients
CHIA-LIN CHANG, KEVIN CHIH-YANG HUANG, TSUNG-WEI CHEN, WILLIAM TZU-LIANG CHEN, TAO-WEI KE, YIH-FARNG LIOU, K.S. CLIFFORD CHAO and SHU-FEN CHIANG

In Vivo July 2023, 37 (4) 1552-1561; DOI: https://doi.org/10.21873/invivo.13240

Main menu

User menu

Search

Rectal cancer

Pages